Literature DB >> 1167710

HL-A linked genetic control of immune response in man.

M J Haverkorn, B Hofman, N Masurel, J J Rood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1167710     DOI: 10.1111/j.1600-065x.1975.tb01554.x

Source DB:  PubMed          Journal:  Transplant Rev        ISSN: 0082-5948


× No keyword cloud information.
  6 in total

1.  A new antigen system expressed in human endothelial cells.

Authors:  J R Moraes; P Stastny
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

2.  Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens.

Authors:  A Jepson; W Banya; F Sisay-Joof; M Hassan-King; C Nunes; S Bennett; H Whittle
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Specific immune responses after booster immunization with tetanus toxoid in man: study of kinetics, family segregation, and linkage to HLA of in vitro lymphocyte proliferative responses and serum-antibody responses.

Authors:  J J Ballet; C Rabian-Herzog; M Lathrop; J F Bourge; M Agrapart; J Drouet; J M Lalouel; J Dausset
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

4.  Nickel contact sensitivity in women and HLA antigens.

Authors:  M Dumont-Fruytier; D Van Neste; M De Bruyere; D Tennstedt; J M Lachapelle
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

5.  In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.

Authors:  D L Mann; N Mendell; C R Kahn; A H Johnson; A Rosenthal
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

6.  Detection and characterization of human serum antibodies to polycyclic aromatic hydrocarbon diol-epoxide DNA adducts.

Authors:  M J Newman; B A Light; A Weston; D Tollurud; J L Clark; D L Mann; J P Blackmon; C C Harris
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.